Cargando…
LyeTx I-b Peptide Attenuates Tumor Burden and Metastasis in a Mouse 4T1 Breast Cancer Model
Cationic anticancer peptides have exhibited potent anti-proliferative and anti-inflammatory effects in neoplastic illness conditions. LyeTx I-b is a synthetic peptide derived from Lycosa erythrognatha spider venom that previously showed antibiotic activity in vitro and in vivo. This study focused on...
Autores principales: | Abdel-Salam, Mostafa A. L., Pinto, Bárbara, Cassali, Geovanni, Bueno, Lilian, Pêgas, Gabriela, Oliveira, Fabrício, Silva, Irismara, Klein, André, de Souza-Fagundes, Elaine Maria, de Lima, Maria Elena, Carvalho-Tavares, Juliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466574/ https://www.ncbi.nlm.nih.gov/pubmed/34572719 http://dx.doi.org/10.3390/antibiotics10091136 |
Ejemplares similares
-
PEGylation of the antimicrobial peptide LyeTx I-b maintains structure-related biological properties and improves selectivity
por: Moreira Brito, Júlio César, et al.
Publicado: (2022) -
Synthesis and antimicrobial evaluation of two peptide LyeTx I derivatives modified with the chelating agent HYNIC for radiolabeling with technetium-99m
por: Fuscaldi, Leonardo Lima, et al.
Publicado: (2016) -
Intravitreal injection of the synthetic peptide LyeTx I b, derived from a spider toxin, into the rabbit eye is safe and prevents neovascularization in a chorio-allantoic membrane model
por: Silva, Flavia Rodrigues da, et al.
Publicado: (2018) -
LyeTxI-b, a Synthetic Peptide Derived From a Spider Venom, Is Highly Active in Triple-Negative Breast Cancer Cells and Acts Synergistically With Cisplatin
por: de Avelar Júnior, Joaquim Teixeira, et al.
Publicado: (2022) -
LyeTxI-b, a Synthetic Peptide Derived From Lycosa erythrognatha Spider Venom, Shows Potent Antibiotic Activity in Vitro and in Vivo
por: Reis, Pablo V. M., et al.
Publicado: (2018)